427 related articles for article (PubMed ID: 18925637)
21. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
22. Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.
Ishigaki S; Fujioka Y; Okada Y; Riku Y; Udagawa T; Honda D; Yokoi S; Endo K; Ikenaka K; Takagi S; Iguchi Y; Sahara N; Takashima A; Okano H; Yoshida M; Warita H; Aoki M; Watanabe H; Okado H; Katsuno M; Sobue G
Cell Rep; 2017 Jan; 18(5):1118-1131. PubMed ID: 28147269
[TBL] [Abstract][Full Text] [Related]
23. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
[TBL] [Abstract][Full Text] [Related]
24. Dyrk1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice.
Yin X; Jin N; Shi J; Zhang Y; Wu Y; Gong CX; Iqbal K; Liu F
Sci Rep; 2017 Apr; 7(1):619. PubMed ID: 28377597
[TBL] [Abstract][Full Text] [Related]
25. Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.
Luk C; Giovannoni G; Williams DR; Lees AJ; de Silva R
J Neurosci Methods; 2009 May; 180(1):34-42. PubMed ID: 19427527
[TBL] [Abstract][Full Text] [Related]
26. Transmission of tauopathy strains is independent of their isoform composition.
He Z; McBride JD; Xu H; Changolkar L; Kim SJ; Zhang B; Narasimhan S; Gibbons GS; Guo JL; Kozak M; Schellenberg GD; Trojanowski JQ; Lee VM
Nat Commun; 2020 Jan; 11(1):7. PubMed ID: 31911587
[TBL] [Abstract][Full Text] [Related]
27. Regulation and differential expression of tau mRNA isoforms as oligodendrocytes mature in vivo: implications for myelination.
LoPresti P
Glia; 2002 Mar; 37(3):250-7. PubMed ID: 11857683
[TBL] [Abstract][Full Text] [Related]
28. Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy.
Sealey MA; Vourkou E; Cowan CM; Bossing T; Quraishe S; Grammenoudi S; Skoulakis EMC; Mudher A
Neurobiol Dis; 2017 Sep; 105():74-83. PubMed ID: 28502805
[TBL] [Abstract][Full Text] [Related]
29. Tau isoform expression and phosphorylation in marmoset brains.
Sharma G; Huo A; Kimura T; Shiozawa S; Kobayashi R; Sahara N; Ishibashi M; Ishigaki S; Saito T; Ando K; Murayama S; Hasegawa M; Sobue G; Okano H; Hisanaga SI
J Biol Chem; 2019 Jul; 294(30):11433-11444. PubMed ID: 31171723
[TBL] [Abstract][Full Text] [Related]
30. Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis.
Usarek E; Kuźma-Kozakiewicz M; Schwalenstöcker B; Kaźmierczak B; Münch C; Ludolph AC; Barańczyk-Kuźma A
Neurochem Res; 2006 May; 31(5):597-602. PubMed ID: 16770730
[TBL] [Abstract][Full Text] [Related]
31. Tau isoform expression and regulation in human cortical neurons.
Deshpande A; Win KM; Busciglio J
FASEB J; 2008 Jul; 22(7):2357-67. PubMed ID: 18263702
[TBL] [Abstract][Full Text] [Related]
32. Tau Exon 10 Inclusion by PrP
Lidón L; Llaó-Hierro L; Nuvolone M; Aguzzi A; Ávila J; Ferrer I; Del Río JA; Gavín R
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065232
[TBL] [Abstract][Full Text] [Related]
33. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
[TBL] [Abstract][Full Text] [Related]
34. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
35. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
36. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes.
Gorath M; Stahnke T; Mronga T; Goldbaum O; Richter-Landsberg C
Glia; 2001 Oct; 36(1):89-101. PubMed ID: 11571787
[TBL] [Abstract][Full Text] [Related]
37. Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model.
Schoch KM; DeVos SL; Miller RL; Chun SJ; Norrbom M; Wozniak DF; Dawson HN; Bennett CF; Rigo F; Miller TM
Neuron; 2016 Jun; 90(5):941-7. PubMed ID: 27210553
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
[TBL] [Abstract][Full Text] [Related]
39. Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration.
Levy SF; Leboeuf AC; Massie MR; Jordan MA; Wilson L; Feinstein SC
J Biol Chem; 2005 Apr; 280(14):13520-8. PubMed ID: 15671021
[TBL] [Abstract][Full Text] [Related]
40. Directly Reprogrammed Neurons Express MAPT and APP Splice Variants Pertinent to Ageing and Neurodegeneration.
Habekost M; Qvist P; Denham M; Holm IE; Jørgensen AL
Mol Neurobiol; 2021 May; 58(5):2075-2087. PubMed ID: 33415685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
